CVE-2022-46355
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE...
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.
Attack profile
How easy it is to exploit
- Attack vector
- Network
- Complexity
- Low
- Privileges needed
- None
- User interaction
- None
What an attacker can affect
- Confidentiality
- High
- Integrity
- None
- Availability
- None
Exploit likelihood
What each source reports
NVD Score used
7.5
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.
- Record
CVE-2022-46355- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
CVE List
7.5
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.
- Record
CVE-2022-46355- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
EUVDEUVD-2022-49171
7.5
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.
- Record
EUVD-2022-49171- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Updated
- 2026-11-02
GitHub AdvisoriesGHSA-rmxv-hrvc-7c4x
7.5
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE...
A vulnerability has been identified in SCALANCE X204RNA (HSR) (All versions < V3.2.7), SCALANCE X204RNA (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (HSR) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP) (All versions < V3.2.7), SCALANCE X204RNA EEC (PRP/HSR) (All versions < V3.2.7). The affected products are vulnerable to an "Exposure of Sensitive Information to an Unauthorized Actor" vulnerability by leaking sensitive data in the HTTP Referer.
- Record
GHSA-rmxv-hrvc-7c4x- CVSS 3.1
- 7.5 High
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N - Weakness
- CWE-200
- Updated
- 2026-11-02
Affected products
- siemens scalance x204rna (hsr)
- siemens scalance x204rna (prp)
- siemens scalance x204rna eec (hsr)
- siemens scalance x204rna eec (prp)
- siemens scalance x204rna eec (prp/hsr)
- siemens 6gk5204-0ba00-2kb2 firmware
- siemens 6gk5204-0ba00-2mb2 firmware
- siemens 6gk5204-0bs00-2na3 firmware
- siemens 6gk5204-0bs00-3la3 firmware
- siemens 6gk5204-0bs00-3pa3 firmware
History
| Recorded | Changed | Sources |
|---|---|---|
| first indexed | CVE List, EUVD, GitHub Advisories, NVD |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2022-46355 is a high vulnerability (CVSS 7.5) in Siemens Scalance X204rna (hsr), published December 13, 2022. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.64%, the 51st percentile. No source names a fixed version.